Riduzione del rischio di morte del 30%
Search Results for: Aspirina e Omega 3 possono ridurre il rischio di cancro al colon
Here's what we've found for you
Linee guida sull’assistenza all’aborto
Queste linee guida riguardano l’assistenza alle donne di qualsiasi età […]
Tumore del colon retto, nuova terapia per forma aggressiva
Con gene di Braf mutato. Combinazione allunga sopravvivenza
Depressione nella mezza età e da anziani aumenta rischio demenza
Studio, significativo impatto sul cervello
Fumo, per osservatorio riduzione del rischio regole Oms obsolete
Mohre: estendere il No Tobacco Day all’intero mese di maggio
Validation and Feasibility of PETS-Stroke: A Patient-Reported Measure of Treatment Burden After Stroke
Stroke, Ahead of Print. BACKGROUND:Treatment burden is the workload of health care for people with long-term conditions and the impact on wellbeing. A validated measure of treatment burden for use as an outcome measure in stroke trials is needed. We adapted a patient-reported measure of treatment burden in multimorbidity, Patient Experience With Treatment and Self-Management (PETS), version 2.0, to create a stroke-specific measure, PETS-stroke, and examined its psychometric properties.METHODS:We conducted an observational cohort study. Stroke and transient ischemic attack survivors were recruited between February 2022 to June 2023 from 10 hospitals in the United Kingdom and through the Scottish Health Research Register. Participants completed the PETS-stroke questionnaire along with 3 other patient-reported measures (the Stroke Southampton Self-Management Questionnaire, the Satisfaction With Stroke Care Measure, and the Shortened Stroke Impact Scale). We performed confirmatory factor analysis to test the factor structure of the PETS-stroke. We assessed Spearman rank correlations between PETS-stroke and other patient-reported measures to determine convergent validity. An intraclass correlation coefficient was performed to assess test-retest reliability. Proportions of missing data along with feedback from qualitative interviews were used to determine feasibility. T-tests were conducted to examine variations in PETS-stroke scores based on multimorbidity and socioeconomic factors.RESULTS:Three hundred eighty-one participants were included (mean age, 68.2 [SD, 11.2] years; female, 43.3%). The best fit was achieved with a 9-factor structure, and internal consistency was good (Omega values, 0.729–0.921). The factor loadings for the individual indicator items across 8 of the 9 domains were moderate to strong. All domains of PETS-stroke showed moderate to strong correlations with at least one other patient-reported measure. Test-retest reliability was good for all domains (intraclass correlation coefficient >0.7). Qualitative feedback on feasibility was positive: participants found the questionnaire to be easy and quick to complete, and missing data were within acceptable limits for 7 domains. PETS-stroke scores significantly differed based on multimorbidity in 3 domains and in 8 domains based on socioeconomic status.CONCLUSIONS:Psychometric performance suggests that PETS-stroke is a valid and feasible measure of treatment burden after stroke.
Ast di Ascoli, in campo strategie per ridurre le liste d'attesa
Acquistate 11.804 prestazioni di specialistica ambulatoriale
Nuova linea guida per la diagnosi e il trattamento dell’ipertensione
Una nuova linea guida sviluppata da Hypertension Canada mira a […]
Intravenous Lidocaine for Gut Function Recovery
To the Editor Dr Paterson and colleagues conducted a randomized clinical trial to evaluate the effect of perioperative IV lidocaine on return of gut function after elective minimally invasive colon resection. I was surprised by the lack of discussion regarding the observed difference in postoperative opioid consumption between the lidocaine and placebo groups and its potential impact on the study’s findings.
ESMO: scala aggiornata per misurare il beneficio clinico dei trattamenti contro il cancro
L’European Society for Medical Oncology (ESMO) ha pubblicato l’ultima versione della […]
'Sos cure, attesa domani sentenza Tar sul Tariffario nazionale'
FederAnisap:’Se parere negativo a rischio strutture accreditate’
Ripensare la diagnosi di BPCO per migliorarne l’accuratezza e la diagnosi precoce
I ricercatori guidati dall’Università dell’Alabama a Birmingham hanno perfezionato e […]
Gli integratori di vitamina D aiutano a preservare la lunghezza dei telomeri negli anziani
Gli integratori di vitamina D possono aiutare a preservare la […]
Un bambino su 10 è prematuro, un test prevede il rischio
Alla 16ima settimana di gestazione con un esame del sangue
Pnrr Sanità: Uil Marche, “Servizi carenti e fondi a rischio”
Mazzucchelli, ‘dai numeri quadro assolutamente insoddisfacente’
In Italia 441 giorni di attesa per l'accesso alle nuove cure contro i tumori
Ostacoli anche dai prontuari terapeutici. Ritardi territoriali per la cura innovativa nel cancro della prostata